Voyager Therapeutics, Inc. (VYGR) — research page
US · us-cm-kg/NASDAQ/VYGR · as of 2026-11-08
Identity and listing
The issuer is Voyager Therapeutics, Inc., listed on NASDAQ under ticker VYGR, with ISIN US92915B1061 and LEI 54930082S4XVR0ZWCC74. The security type is Corporate, the segment is not on the record, the sector is 2836 Biological Products, (No Diagnostic Substances), and the jurisdiction is United States, Delaware. The listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Voyager Therapeutics, Inc. | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | VYGR | source · 2026-11-08 |
| ISIN | US92915B1061 | source · 2026-11-08 |
| LEI | 54930082S4XVR0ZWCC74 | source · 2026-11-08 |
| security type | Corporate | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2836 Biological Products, (No Diagnostic Substances) | source · 2026-11-08 |
| jurisdiction | United States — Delaware | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 79 filings across 34 filing days in the window 2025-11-08 to 2026-11-08. The median gap between filing days is 7 days. The latest filing is dated 2026-11-05, 3 days before the record date of 2026-11-08, and is of type takeover. The NASDAQ median is 6.0 days of cadence gap, 52 filings and 5.0 days of latency across 4359 issuers. The sector median is 5.5 days of cadence gap, 65.5 filings and 4.0 days of latency across 176 issuers. The issuer's cadence gap of 7 days is above the NASDAQ median of 6.0 days and above the sector median of 5.5 days. Its 79 filings are above the NASDAQ median of 52 and above the sector median of 65.5. Its latency of 3 days is below the NASDAQ median of 5.0 days and below the sector median of 4.0 days.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 79 | 7 | 3 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2836 Biological Products, (No Diagnostic Substances) (176 issuers) | 65.5 | 5.5 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-05 | takeover | 8-K | 8-K — 8-K (items 2.01) |
| 2026-11-05 | results | 10-Q | 10-Q — 10-Q |
| 2026-11-03 | directors_dealings | 4 | 4 — 4 |
| 2026-11-03 | directors_dealings | 4 | 4 — 4 |
| 2026-10-21 | director_change | 8-K | 8-K — 8-K (items 5.02,9.01) |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor is not on the record, because the latest annual report cover carries no dei:AuditorName tag. The auditor's location is not on the record. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting or name change lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.
Orderability
The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's investor-relations page.
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.
Sources
8 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0001640266.json (identity.jurisdiction)
- 10.4
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.5
- https://mcp.us-cm-kg.ai/events/NASDAQ/VYGR (the disclosure lines)
- 10.6
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.7
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.8
- https://mcp.us-cm-kg.ai/record/NASDAQ/VYGR (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"US92915B1061"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:54ff3c4357a8d067.